Nature's Sunshine Products, a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today.

Company profile
Ticker
NATR
Exchange
Website
CEO
Terrence O. Moorehead
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
NATR Distribution (M) SDN. BHD. • Nature’s Sunshine (Far East) Limited • Nature’s Sunshine Hong Kong Limited • Nature’s Sunshine Marketing Ltda. • Nature’s Sunshine Products de Honduras, S.A. de C.V. • Nature’s Sunshine Products de Nicaragua, S.A. • Nature’s Sunshine Products de Panamá, S.A. • Nature’s Sunshine Products del Ecuador, S.A. • Nature’s Sunshine Products International Distribution B.V. • Nature’s Sunshine Products of Russia, Inc. ...
IRS number
870327982
NATR stock data
Press releases
Nature's Sunshine Reports First Quarter 2022 Results
5 May 22
Nature's Sunshine Appoints Martin Gonzalez as Executive Vice President of Global Supply Chain
4 May 22
Nature's Sunshine Sets First Quarter 2022 Conference Call for Thursday, May 5, 2022, at 5:00 p.m. ET
21 Apr 22
Nature's Sunshine Celebrates 50 Years of Sharing the Healing Power of Nature
12 Apr 22
Nature's Sunshine Chief Executive Officer Wins 2022 CEO Today Global Award
5 Apr 22
Analyst ratings and price targets
Calendar
5 May 22
26 Jun 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 66.54M | 66.54M | 66.54M | 66.54M | 66.54M | 66.54M |
Cash burn (monthly) | 6.55M | 2.06M | (no burn) | (no burn) | 2.64M | (no burn) |
Cash used (since last report) | 18.81M | 5.92M | n/a | n/a | 7.59M | n/a |
Cash remaining | 47.73M | 60.62M | n/a | n/a | 58.95M | n/a |
Runway (months of cash) | 7.3 | 29.4 | n/a | n/a | 22.3 | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jun 22 | Moorehead Terrence | Performance Units Common Shares | Grant | Acquire A | No | No | 0 | 41,000 | 0 | 41,000 |
16 Jun 22 | Edward Silcock | Performance Units Common Shares | Grant | Acquire A | No | No | 0 | 12,000 | 0 | 12,000 |
16 Jun 22 | Baty Joseph W | Performance Units Common Shares | Grant | Acquire A | No | No | 0 | 13,000 | 0 | 13,000 |
16 Jun 22 | Daniel C Norman | Performance Units Common Shares | Grant | Acquire A | No | No | 0 | 12,000 | 0 | 12,000 |
16 Jun 22 | Bryant J Yates | Performance Units Common Shares | Grant | Acquire A | No | No | 0 | 12,000 | 0 | 12,000 |
Institutional ownership, Q1 2022
74.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 96 |
Opened positions | 13 |
Closed positions | 12 |
Increased positions | 37 |
Reduced positions | 29 |
13F shares | Current |
---|---|
Total value | 250.89M |
Total shares | 14.58M |
Total puts | 0 |
Total calls | 12.1K |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
FOSUF Fosun International | 2.93M | $49.27M |
Wynnefield Capital | 2.4M | $40.35M |
Paradigm Capital Management | 1.08M | $18.15M |
Prescott Group Capital Management, L.L.C. | 1.01M | $16.99M |
Vanguard | 822.08K | $13.83M |
BLK Blackrock | 773.19K | $13.01M |
Renaissance Technologies | 707.2K | $11.9M |
Dimensional Fund Advisors | 560.59K | $9.43M |
Red Mountain Capital Partners | 344.93K | $5.21M |
Acadian Asset Management | 338.1K | $5.68M |
Financial report summary
?Competition
LifevantageManagement Discussion
- International operations have provided, and are expected to continue to provide, a significant portion of our total net sales. As a result, total net sales will continue to be affected by fluctuations in the U.S. dollar against foreign currencies. In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, in addition to comparing the percent change in net sales from one period to another in U.S. dollars, we present net sales excluding the impact of foreign exchange fluctuations. We compare the percentage change in net sales from one period to another period by excluding the effects of foreign currency exchange as shown below. Net sales excluding the impact of foreign exchange fluctuations is not a U.S. GAAP financial measure and removes from net sales in U.S. dollars the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries, by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period. We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. However, net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP. Throughout the last five years, foreign currency exchange rates have fluctuated significantly. See Item 3. Quantitative and Qualitative Disclosures about Market Risk.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absolute, accelerated, agreed, albeit, bore, broadly, Bureau, carryforward, charge, confidence, conflict, consumer, counter, created, desired, distributor, environment, escalate, existing, February, fewer, floating, forty, geography, highest, incremental, inflationary, instituted, invasion, matter, military, monitoring, neighboring, nonessential, payment, persistent, physical, prevailing, proximity, quarantine, reconsider, repaid, resolution, rest, Russia, scope, sensitivity, situation, size, spend, spending, stringent, sustained, Taiwan, Ukraine, unable, unemployment
Removed:
allocation, approach, bear, beginning, calculating, cannabidiol, CBD, collected, governmental, intraperiod, maintained, methodology, rapidly, remitted, sheet, Simplifying, varying, volatility, weakening
Financial reports
Current reports
8-K
Departure of Directors or Certain Officers
17 Jun 22
8-K
Departure of Directors or Certain Officers
2 Jun 22
8-K
Nature's Sunshine Reports First Quarter 2022 Results
6 May 22
8-K
Nature's Sunshine Reports Record Fourth Quarter and Full Year 2021 Financial Results
8 Mar 22
8-K
Departure of Directors or Certain Officers
29 Dec 21
8-K
Results of Operations and Financial Condition
4 Nov 21
8-K
Departure of Directors or Certain Officers
24 Sep 21
8-K
Departure of Directors or Certain Officers
24 Aug 21
8-K
Amendment to Operating Agreement of
16 Aug 21
8-K
Nature's Sunshine Reports Record Second Quarter 2020 Results
5 Aug 21
Registration and prospectus
S-8
Registration of securities for employees
26 Aug 21
S-3/A
Shelf registration (amended)
28 Jul 21
S-3
Shelf registration
11 Jul 21
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Jun 15
S-8
Registration of securities for employees
4 Jun 13
S-8
Registration of securities for employees
28 Dec 09
8-A12B
Registration of securities on exchange
5 Oct 09
10-12G
Registration of securities
11 Feb 09
SC TO-I/A
Issuer tender offer statement (amended)
7 Sep 05
SC TO-I/A
Issuer tender offer statement (amended)
1 Sep 05
Other
EFFECT
Notice of effectiveness
3 Aug 21
CORRESP
Correspondence with SEC
28 Jul 21
UPLOAD
Letter from SEC
15 Jul 21
UPLOAD
Letter from SEC
10 Apr 16
CORRESP
Correspondence with SEC
6 Apr 16
UPLOAD
Letter from SEC
4 Apr 16
UPLOAD
Letter from SEC
20 Aug 15
CORRESP
Correspondence with SEC
23 Jul 15
UPLOAD
Letter from SEC
13 Jul 15
UPLOAD
Letter from SEC
23 Jul 12
Ownership
4
NATURES SUNSHINE PRODUCTS / Rong Yang ownership change
21 Jun 22
3
NATURES SUNSHINE PRODUCTS / Rong Yang ownership change
21 Jun 22
4
NATURES SUNSHINE PRODUCTS / Nathan G Brower ownership change
17 Jun 22
4
NATURES SUNSHINE PRODUCTS / Bryant J Yates ownership change
17 Jun 22
4
NATURES SUNSHINE PRODUCTS / Daniel C Norman ownership change
17 Jun 22
4
NATURES SUNSHINE PRODUCTS / JOSEPH W BATY ownership change
17 Jun 22
4
NATURES SUNSHINE PRODUCTS / Edward Silcock ownership change
17 Jun 22
4
NATURES SUNSHINE PRODUCTS / Terrence Moorehead ownership change
17 Jun 22
4
NATURES SUNSHINE PRODUCTS / Terrence Moorehead ownership change
9 May 22
4
NATURES SUNSHINE PRODUCTS / John Christopher Teets ownership change
6 May 22
Patents
Utility
Phytocomplexes Exhibiting Multiple, Synergistic Antioxidant Activities Useful In Foods, Dietary Supplements, Cosmetics and Pharmaceutical Preparations
5 Aug 20
Compositions comprising apple, grape, green tea, and olive extracts are presented herein.
Utility
Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations
7 Oct 19
Compositions comprising apple, grape, green tea, and olive extracts are presented herein.
Transcripts
2022 Q1
Earnings call transcript
8 May 22
2021 Q4
Earnings call transcript
9 Mar 22
2021 Q3
Earnings call transcript
7 Nov 21
2021 Q2
Earnings call transcript
7 Aug 21
2021 Q1
Earnings call transcript
9 May 21
2020 Q4
Earnings call transcript
11 Mar 21
2020 Q3
Earnings call transcript
9 Nov 20
2020 Q2
Earnings call transcript
8 Aug 20
2020 Q1
Earnings call transcript
12 May 20
2019 Q4
Earnings call transcript
11 Mar 20
Reddit threads
Daily Discussion Thread - May 5th, 2022
5 May 22
Daily Discussion Thread - May 4th, 2022
4 May 22
Daily Discussion Thread - March 8th, 2022
8 Mar 22
Daily Discussion Thread - March 7th, 2022
7 Mar 22
Daily Discussion Thread - November 4th, 2021
4 Nov 21
Daily Discussion Thread - November 3rd, 2021
3 Nov 21
Daily Discussion Thread - August 5th, 2021
5 Aug 21
Daily Discussion Thread - August 4th, 2021
4 Aug 21